← Open Payments lookup

DAVID WABWILE: Open Payments

NPI 1861162604 · DERRY, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$748 in 31 payments from 11 companies in 2025. Trend: 2023 $20 · 2024 $284 · 2025 $748

Food & beverage: $748
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.8$191
Teva Pharmaceuticals USA, Inc.4$122
Janssen Pharmaceuticals, Inc5$100
Lundbeck LLC3$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$54
Alkermes, Inc.2$47
Collegium Pharmaceutical, Inc.2$46
ABBVIE INC.2$29
Takeda Pharmaceuticals U.S.A., Inc.1$29
E.R. Squibb & Sons, L.L.C.1$26

Products named: ABILIFY MAINTENA, REXULTI, INVEGA SUSTENNA, UZEDY, ABILIFY ASIMTUFII, CAPLYTA, AUSTEDO XR, ARISTADA.

Industry payments across NH — which companies pay providers there.